Abstract
PL02 Presentation Time: 1:45 PM: HDR Monotherapy for Low and Intermediate Risk Prostate Cancer: Update of a Randomized Trial
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have